Fiasp (insulin aspart, human) 3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog] 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]
NO BLACK BOX WARNING
Dosage & administration See Full Prescribing Information for important administration and dosage instructions .
* Subcutaneous injection : * Inject subcutaneously within 5-10 minutes before a meal into the abdominal area, thigh, buttocks or upper arm. * Rotate injection sites within the same region from one injection to the next to reduce risk of lipodystrophy and localized cutaneous amyloidosis. * Should generally be used in regimens with an intermediate- or long-acting insulin. * Continuous Subcutaneous Infusion (Insulin Pump) : * Refer to the insulin infusion pump user manual to see if NOVOLOG can be used. Use in accordance with the insulin pump instructions for use.* Administer by continuous subcutaneous infusion using an insulin pump in a region recommended in the instructions from the pump manufacturer. * Rotate the injection sites within the same region from one injection to the next to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. * Do not mix with other insulins or diluents in the pump. * Intravenous Administration : * Dilute NOVOLOG to concentrations from 0.05 unit/mL to 1 unit/mL insulin aspart in infusion systems using polypropylene infusion bags. * NOVOLOG is stable in infusion fluids such as 0.9% Sodium Chloride Injection, USP. * Individualize and adjust the dosage of NOVOLOG based on route of administration, the individual's metabolic needs, blood glucose monitoring results and glycemic control goal . * Dosage adjustments may be needed with changes in physical activity, changes in meal patterns (i.e., macronutrient content or timing of food intake), changes in renal or hepatic function or during acute illness .
drug label Fiasp prescribing information
people also ask Fiasp FAQs How is the dosage of Fiasp? Fiasp is available in 4 dosages, including 100 unt/ml Cartridge 3 ml, 100 unt/ml Pen Injector 3 ml, 100 unt/ml Sol and 100 unt/ml Sol
What does Fiasp treat? Fiasp treats Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus and Hyperglycemia
What is Fiasp made of? Fiasp contains insulin aspart, human which is a Insulin Analog
How Is Fiasp Administered? Fiasp is administered as a Injectable
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
